Drugs / M366
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT02712554 Comparator | Jun → Sep 2015 | — | Charleston Laboratories, Inc | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | M366 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02712554 ↗ |
| Route | Oral | “M366 22.5 mg/975 mg tablet by mouth” NCT02712554 ↗ |